TEL: (212)616-4899

NRx Pharmaceuticals Investigation Contact Form

An investigation has commenced into the fairness of the 2021 de-SPAC merger of NRx Pharmaceuticals Inc. (f/k/a Big Rock Partners Acquisition Corp.) (“NRXP” or the "Company") (NASDAQ: NRXP) . Shortly after the NRXP 2021 de-SPAC merger closed, NRXP stock began spiraling downwards.

The NRXP de-SPAC merger investigation concerns this transaction unfairly harmed stockholders and whether all material facts were properly disclosed to stockholders.

Keep Me Informed

The Klein Law Firm does not share your information with others. There is no cost or obligation. This submission does not create an attorney-client relationship. If we believe that you might be an appropriate lead plaintiff, we will contact you to discuss whether to establish an attorney-client relationship.